Kelsey Sharrad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kelsey Sharrad has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Adrian Esterman
University of South Australia, Adelaide, Australia
1 shared publication Andrew Tai
Respiratory and Sleep Medicine, Women's & Children's Hospital, Adelaide, Australia
1 shared publication- Helen Margaret Stallman
School of Psychology, Social Work and Social Policy, University of South Australia, Adelaide, South Australia, Australia
1 shared publication - Kristin Carson-Chahhoud
Adelaide Medical School; The University of Adelaide; Adelaide Australia
1 shared publication - Liem Tran
JBI, Faculty of Health and Medical Sciences, School of Public Health, University of Adelaide, Adelaide, South Australia, Australia
1 shared publication Nicola Spurrier
SA Health, Department for Health and Ageing, Adelaide, South Australia, Australia
1 shared publication
Latest Publications
- 27 February 2020
- Published by Taylor & Francis in Journal of Asthma
- Vol. 58 (6) , 759-769
Pharmacological interventions for the treatment of psychological distress in patients with asthma: a systematic review and meta-analysis
OBJECTIVE: To evaluate the effectiveness and safety of pharmacological interventions for the treatment of psychological distress in people with asthma. DATA SOURCES: Electronic searches were performed in Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, PubMed/Medline, Embase, PsycInfo, Health Technology Assessment Database and Web of Science (inception to April 2019). STUDY SELECTIONS: Included studies were randomised controlled trials (RCT) or controlled clinical trials investigating the effect of pharmacological interventions for psychological distress in people with asthma. Records were screened and data extracted by two independent authors into standardised pilot-tested extraction templates. Data was analysed according to standard Cochrane methodology and entered into Review Manager Software version 5.3. RESULTS: From 5,689 studies, six RCTs (n = 215) met inclusion criteria and were included in the systematic review, of which four studies were included in the meta-analysis. A meta-analysis of four studies (n = 158) indicated no evidence of an effect for selective serotonin reuptake inhibitors (Citalopram or Escitalopram) on reduction of psychological distress in adult patients with asthma. Similarly, antiepileptic medication (Levetiracetam) was no better than placebo in the treatment of psychological distress in people with asthma. Adverse events were poorly reported across all studies but were slightly increased among intervention participants compared to control participants. CONCLUSIONS: There was great heterogeneity between studies and overall poor methodological quality providing insufficient evidence to make recommendations for or against the use of pharmacotherapy in asthma patients with psychological distress. Further confirmatory trials are warranted to make recommendations for clinical practice.
- 27 February 2020
- Published by Taylor & Francis in Journal of Asthma
- Vol. 58 (6) , 759-769
Pharmacological interventions for the treatment of psychological distress in patients with asthma: a systematic review and meta-analysis
OBJECTIVE: To evaluate the effectiveness and safety of pharmacological interventions for the treatment of psychological distress in people with asthma. DATA SOURCES: Electronic searches were performed in Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, PubMed/Medline, Embase, PsycInfo, Health Technology Assessment Database and Web of Science (inception to April 2019). STUDY SELECTIONS: Included studies were randomised controlled trials (RCT) or controlled clinical trials investigating the effect of pharmacological interventions for psychological distress in people with asthma. Records were screened and data extracted by two independent authors into standardised pilot-tested extraction templates. Data was analysed according to standard Cochrane methodology and entered into Review Manager Software version 5.3. RESULTS: From 5,689 studies, six RCTs (n = 215) met inclusion criteria and were included in the systematic review, of which four studies were included in the meta-analysis. A meta-analysis of four studies (n = 158) indicated no evidence of an effect for selective serotonin reuptake inhibitors (Citalopram or Escitalopram) on reduction of psychological distress in adult patients with asthma. Similarly, antiepileptic medication (Levetiracetam) was no better than placebo in the treatment of psychological distress in people with asthma. Adverse events were poorly reported across all studies but were slightly increased among intervention participants compared to control participants. CONCLUSIONS: There was great heterogeneity between studies and overall poor methodological quality providing insufficient evidence to make recommendations for or against the use of pharmacotherapy in asthma patients with psychological distress. Further confirmatory trials are warranted to make recommendations for clinical practice.